Articles

Patient navigators facilitated almost 700 cancer screenings among Latino Medicare beneficiaries through a cancer prevention and treatment demonstration project for ethnic and racial minorities at the University of Medicine and Dentistry of New Jersey (UMDNJ). The project seeks to address disparities in cancer screening rates in the elderly Latino population in the Newark, New Jersey, area. The project also is evaluating the impact of navigators to facilitate that screening.

Read More ›

Multiple myeloma (MM) is a disease with variable presentation, disease trajectory, prognosis, and options for treatment. Integrating the plethora of scientific discovery relative to plasma cell disorders, molecular and cytogenetic attributes and their implications for prognosis and treatment, identification of key components of the bone marrow micro - environment, and the development of novel therapies targeting many of these attributes requires a thorough review of multiple sources of information. Multiple Myeloma: A Textbook for Nurses, edited by Joseph D. Read More ›


Today, plastic surgery has achieved great strides in restoring appearance and function.1 In patients with cancer, reconstructive surgery must allow for adequate resection of tumor with clear margins, facilitate initiation of adjuvant therapy, and maximize quality of life by making the most of function and esthetics. Read More ›

Data published in the Journal of the American Medical Association last week indicate that for 20% of women with early-stage breast cancer, removing malignant lymph nodes from the armpit does not improve survival or prevent recurrence. As expected, women in the phase III trial who underwent complete axillary lymph node dissection (ALND) had higher rates of lymphedema than those who had sentinel lymph node dissection (SLND) alone (P <.001). Read More ›

The FDA held a public meeting on Tuesday to assess whether stricter criteria are needed when considering oncology drugs for accelerated approval. Measures enacted in 1992 allow the FDA to grant accelerated approval for drugs targeted at unmet needs in cancer based solely on data from single-arm studies and relying on endpoints other than the standard metric of overall survival. Read More ›

A newly discovered four-gene signature might someday be used to help clinicians distinguish between indolent and aggressive prostate cancer at diagnosis and end the ongoing debate over immediate versus delayed treatment. “The vast majority of prostate cancers would not become life-threatening, even if left untreated. Read More ›

Patients can instantly save up to $200 off their copay with each prescription for PediatRx’s Granisol, the only FDA-approved ready-to-use liquid solution of granisetron. This new copay assistance program also leverages technology to initiate prior approval if a patient’s insurance requires it.
 
Read More ›

Women may be at greater risk for breast cancer if they start hormonal therapy before or soon after menopause, according to a large prospective study. Women who begin therapy 5 or more years after menopause are at less risk.
 
Read More ›

By training men with prostate cancer scheduled for prostatectomy on stress management techniques, nurses can help them raise their immune outcome and lower their mood disturbance. These outcomes, identified in a randomized study, build on the previous discovery that stress management techniques can improve quality of life 1 year postsurgery.
 
Read More ›

Avoiding intermittent high-dose dexamethasone (HD) when administering the vincristine/doxorubicin/dexamethasone (VAD) regimen can reduce the risk for bacterial infection in patients with multiple myeloma (MM), suggest the results of a Japanese study published in the January issue of the International Journal of Hematology.
 
Read More ›

Page 351 of 377


Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: